Alaaeldin Bashier

Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients with Type 2 Diabetes

Alaaeldin Bashier, Azza Khalifa, Elamin Abdelgadir et al. · Oman Medical Journal · 2018 · 48 citations · Full text

The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes

Mohamed Hassanein, Elamin Abdelgadir, Alaaeldin Bashier et al. · Diabetes Research and Clinical Practice · 2019 · 46 citations

Metabolic Syndrome, Diabetes Management, Health Policy +8

The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care

Fatheya Alawadi, Fouzia Rashid, Alaaeldin Bashier et al. · Diabetes Research and Clinical Practice · 2019 · 37 citations

Obesity, Metabolic Syndrome, Nutrition +14

Emirates Diabetes Society Consensus Guidelines for the Management of Type 2 Diabetes Mellitus – 2020

Fatheya Alawadi, Salah Abusnana, Bachar Afandi et al. · Dubai Diabetes and Endocrinology Journal · 2020 · 36 citations · Full text

United Arab Emirates, Cardiometabolic Risk, Socioeconomic Development +20

Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes

Alaaeldin Bashier, Azza Khalifa, Fouzia Rashid et al. · Journal of Clinical Medicine Research · 2017 · 28 citations · Full text